- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
James Morrison, NewsMax Health
Medical marijuana advocates, normally reliable Democratic allies, are publicly opposing a top Democratic representative over her possible plans to run for the U.S. Senate in Florida if Republican incumbent Marco Rubio abandons his seat to campaign for president.
Rep. Debbie Wasserman Schultz, who represents a South Florida district and also serves as chairwoman of the Democratic National Committee, has angered the pot lobby nationwide by expressing concerns that medical marijuana laws lead to widespread abuse, Politico reported Thursday.
Bill Piper, national affairs director of the Drug Policy Alliance in Washington, called on Wasserman Schultz to change her views or face retaliation.
"This issue is evolving very quickly, and hopefully she will evolve," Piper said. "But if she doesn’t, you can expect medical marijuana patients and supporters to dog her on the campaign trail."
His group has formed an alliance with People United for Medical Marijuana in Florida, the national Marijuana Policy Project and Americans for Safe Access to oppose Wasserman Schultz.
The six-term congresswoman last year angered a top Florida Democratic campaign donor, trial lawyer John Morgan, by opposing his efforts to promote a medical marijuana initiative. Morgan spent $4 million of his own money on the effort.
Wasserman Schultz compared medical marijuana shops to black-market dealers of the narcotic pain reliever, OxyContin.
"Other states have shown that lax oversight and ease of access to prescriptions can lead to abuse, fraud, and accidents," she said.
Morgan denounced her action and cited her opposition as an example of why she is "despised" in high-ranking Democratic circles, Politico reported.
Social media have also taken up the cause of the medical marijuana lobby.